BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12487737)

  • 21. [Infiltrating transitional carcinoma of the bladder. 3. Effect of regional lymph node dissemination on the prognosis].
    Escudero Barrilero A; Mateos A; Maganto E; Mayayo T; Pérez Bustamante I; Fernández I; del Hoyo J
    Actas Urol Esp; 1991; 15(4):331-7. PubMed ID: 1772046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radical cystectomy for the treatment of infiltrating bladder carcinoma. Analysis of 15 years].
    González Enguita C; Liédana Torres JM; Roncales Badal A; Martínez Bengoechea J; Gil Sanz MJ; Rioja Sanz LA
    Arch Esp Urol; 1991 May; 44(4):395-402. PubMed ID: 2064441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intra-arterial infusion chemotherapy of advanced bladder cancer].
    Akiyama M; Inoue Y; Yokota K; Sumiyoshi Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1705-8. PubMed ID: 1530337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic value of local vascular infiltration in infiltrating transitional carcinoma of the bladder].
    de Castro F; Sánchez P; Robledo C; Rosell D; Agüera L; Isa W; Robles JE; Zudaire JJ; Berián JM
    Actas Urol Esp; 1992 Apr; 16(4):321-4. PubMed ID: 1636456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined treatment of invasive bladder cancer by intra-arterial infusion chemotherapy of cisplatin with or without other anticancer agents and concurrent radiotherapy--initial response and side effects].
    Eiro I; Kanetsuki I; Takeshita T; Yano T; Uchiyama N; Onohara S; Nakajo M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun; 52(6):793-8. PubMed ID: 1641310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
    [No Abstract]   [Full Text] [Related]  

  • 27. Superficial bladder cancer.
    Itoku KA; Stein BS
    Hematol Oncol Clin North Am; 1992 Feb; 6(1):99-116. PubMed ID: 1556055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of treatment for muscle infiltrating transitional cell bladder cancer.
    Whitmore WF
    Arch Esp Urol; 1990; 43 Suppl 2():219-22. PubMed ID: 2096783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
    Prout GR; Shipley WU; Kaufman DS; Heney NM; Griffin PP; Althausen AF; Bassil B; Nocks BN; Parkhurst EC; Young HH
    J Urol; 1990 Nov; 144(5):1128-34; discussion 1134-6. PubMed ID: 2122007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor embolization to the lymphatic vessel structures of the bladder wall (L+). Its effect on the course of bladder tumors].
    Ricos Torrent JV; Iborra Juan I; Casanova Ramón-Borja J; Monrós Lliso JL; Dumont Martínez R; Solsona Narbón E
    Arch Esp Urol; 1991 Oct; 44(8):965-9. PubMed ID: 1796859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.
    Fung CY; Shipley WU; Young RH; Griffin PP; Convery KM; Kaufman DS; Althausen AF; Heney NM; Prout GR
    J Clin Oncol; 1991 Sep; 9(9):1533-42. PubMed ID: 1875217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder.
    Farrow GM; Utz DC; Rife CC; Greene LF
    Cancer Res; 1977 Aug; 37(8 Pt 2):2794-8. PubMed ID: 406039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment methods as a prognostic factor in eight patients with urachal carcinoma].
    Yamada T; Fukui I; Sekine H; Kihara K; Oshima H
    Hinyokika Kiyo; 1991 Feb; 37(2):113-6. PubMed ID: 2048489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder preserving combined modality therapy for invasive bladder cancer.
    Held J; Volpe H
    Oncol Nurs Forum; 1991; 18(1):49-57. PubMed ID: 2003116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive bladder cancer. A bladder-sparing trial.
    Prout GR; Shipley WU; Kaufman DS; Griffin PP; Heney NM
    Urol Clin North Am; 1991 Aug; 18(3):547-54. PubMed ID: 1877119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intra-arterial infusion chemotherapy for advanced bladder cancer and prostate cancer using reservoir system].
    Sumiyoshi Y; Yokota K; Akiyama M
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):2028-31. PubMed ID: 1877846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organ preservation in superficial bladder cancer.
    Oosterhof GO; Witjes JA; Debruyne FM
    Prog Clin Biol Res; 1991; 370():195-202. PubMed ID: 1924451
    [No Abstract]   [Full Text] [Related]  

  • 38. [Non-radical treatment and bladder conservation in infiltrating tumor of the bladder].
    González Enguita C; Caro Cebrián C; Sánz Vélez JI; Gil Sánz MJ; Martínez Bengoechea J; Urruchi Fernández P; Rioja Sánz LA
    Actas Urol Esp; 1992 Mar; 16(3):240-6. PubMed ID: 1621550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinical survey of advanced bladder cancer: treatment of advanced and non-resectable bladder cancer].
    Naito K; Hasegawa T; Ishida T; Yamamoto H; Mihara S; Komatsu K; Ueki O; Koshida K; Hisazumi H
    Hinyokika Kiyo; 1991 Dec; 37(12):1601-6. PubMed ID: 1785381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bladder sparing approach to muscle invasive carcinoma of the bladder.
    Marino R; Wajsman Z
    Prog Clin Biol Res; 1990; 353():175-8. PubMed ID: 2217416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.